240 related articles for article (PubMed ID: 11069620)
41. A sensitive and restricted enzyme-linked immunosorbent assay for detecting a heterogeneous antibody population in serum from people suffering from a new variant of endemic pemphigus.
Abréu-Vélez AM; Yepes MM; Patiño PJ; Bollag WB; Montoya F
Arch Dermatol Res; 2004 Mar; 295(10):434-41. PubMed ID: 14730452
[TBL] [Abstract][Full Text] [Related]
42. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals.
Hertl M; Amagai M; Sundaram H; Stanley J; Ishii K; Katz SI
J Invest Dermatol; 1998 Jan; 110(1):62-6. PubMed ID: 9424089
[TBL] [Abstract][Full Text] [Related]
43. Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus.
Ishii K; Amagai M; Komai A; Ebihara T; Chorzelski TP; Jablonska S; Ohya K; Nishikawa T; Hashimoto T
Arch Dermatol; 1999 Aug; 135(8):943-7. PubMed ID: 10456343
[TBL] [Abstract][Full Text] [Related]
44. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus.
Brenner S; Bialy-Golan A; Anhalt GJ
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):919-23. PubMed ID: 9204055
[TBL] [Abstract][Full Text] [Related]
45. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.
Cassano N; Mastrandrea V; Tampoia M; Filotico R; Vestita M; Vena GA
J Biol Regul Homeost Agents; 2009; 23(3):197-201. PubMed ID: 19828097
[TBL] [Abstract][Full Text] [Related]
46. Analysis of the Specificity of Auto-Reactive Antibodies to Individual Fragments of the Extracellular Domain of Desmoglein 3 in Patients with Pemphigus Vulgaris.
Kubanov AA; Deryabin DG; Shpilevaya MV; Karamova AE; Nikonorov AA; Larina EN; Aliev TK; Dolgikh DA; Bobik TV; Smirnov IV; Gabibov AG; Kirpichnikov MP
Bull Exp Biol Med; 2021 Aug; 171(4):475-479. PubMed ID: 34542752
[TBL] [Abstract][Full Text] [Related]
47. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals.
Hertl M; Karr RW; Amagai M; Katz SI
J Invest Dermatol; 1998 Apr; 110(4):388-92. PubMed ID: 9540980
[TBL] [Abstract][Full Text] [Related]
48. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.
Müller R; Svoboda V; Wenzel E; Müller HH; Hertl M
Exp Dermatol; 2008 Jan; 17(1):35-43. PubMed ID: 18095943
[TBL] [Abstract][Full Text] [Related]
49. Extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion.
Amagai M; Kàrpàti S; Klaus-Kovtun V; Udey MC; Stanley JR
J Invest Dermatol; 1994 Oct; 103(4):609-15. PubMed ID: 7930691
[TBL] [Abstract][Full Text] [Related]
50. Pemphigus vulgaris localized to the nose and cheeks.
Baykal C; Azizlerli G; Thoma-Uszynski S; Hertl M
J Am Acad Dermatol; 2002 Dec; 47(6):875-80. PubMed ID: 12451372
[TBL] [Abstract][Full Text] [Related]
51. BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3.
Fan JL; Memar O; McCormick DJ; Prabhakar BS
J Immunol; 1999 Dec; 163(11):6228-35. PubMed ID: 10570315
[TBL] [Abstract][Full Text] [Related]
52. Autoantibodies against cell adhesion molecules in pemphigus.
Amagai M
J Dermatol; 1994 Nov; 21(11):833-7. PubMed ID: 7852644
[TBL] [Abstract][Full Text] [Related]
53. Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope.
Evangelista F; Roth AJ; Prisayanh P; Temple BR; Li N; Qian Y; Culton DA; Liu Z; Harrison OJ; Brasch J; Honig B; Shapiro L; Diaz LA
J Autoimmun; 2018 May; 89():171-185. PubMed ID: 29307589
[TBL] [Abstract][Full Text] [Related]
54. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1.
Shirakata Y; Amagai M; Hanakawa Y; Nishikawa T; Hashimoto K
J Invest Dermatol; 1998 Jan; 110(1):76-8. PubMed ID: 9424092
[TBL] [Abstract][Full Text] [Related]
55. Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus.
Huang Y; Li J; Zhu X
Arch Dermatol Res; 2009 Oct; 301(10):703-9. PubMed ID: 18820940
[TBL] [Abstract][Full Text] [Related]
56. T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals.
Veldman CM; Gebhard KL; Uter W; Wassmuth R; Grötzinger J; Schultz E; Hertl M
J Immunol; 2004 Mar; 172(6):3883-92. PubMed ID: 15004196
[TBL] [Abstract][Full Text] [Related]
57. Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus.
Hashimoto T; Komai A; Futei Y; Nishikawa T; Amagai M
Arch Dermatol; 2001 Jun; 137(6):735-8. PubMed ID: 11405762
[TBL] [Abstract][Full Text] [Related]
58. Desmoglein-3 is a target autoantigen in spontaneous canine pemphigus vulgaris.
Olivry T; Joubeh S; Dunston SM; Nishiyama T; Ghohestani RF
Exp Dermatol; 2003 Apr; 12(2):198-203. PubMed ID: 12702149
[TBL] [Abstract][Full Text] [Related]
59. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
[TBL] [Abstract][Full Text] [Related]
60. Identification of desmoglein 1 as autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus.
Kárpáti S; Amagai M; Liu WL; Dmochowski M; Hashimoto T; Horváth A
Exp Dermatol; 2000 Jun; 9(3):224-8. PubMed ID: 10839721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
